Biophysical and chemical effects of fibrin on mesenchymal stromal cell gene expression
Source abstract
Abstract
Mesenchymal stromal cells (MSCs) are multipotent cells that have high expansion yields and fibrin is a native extracellular matrix (ECM) material widely used for cell delivery and surgery. MSCs and fibrin have tremendous potential for tissue engineering applications, but the effect of fibrin on MSCs is not well characterized. The purpose of this study was to analyze the role of fibrin in modulating MSC phenotype by gene expression analysis. The results demonstrate that fibrin up-regulated MSC gene expression of vasculogenic (FLK1, ACTA2, VECAD, SM22 and CNN1), myogenic (MYF5 and MYH13), neurogenic (TH and GFAP) and chondrogenic (COL2A1) markers after 5 days incubation. These gene expression results were supported by induction of expression on the protein level for early lineage-specific markers such as ACTA2, FLK1 and MYF5. The ability of fibrin to modulate MSC gene expression was not affected by matrix pore size (80-110 microm diameter) or Young's modulus (5-25k Pa) and the differential expression of some phenotypic markers could be partially mimicked by other ECM proteins, such as fibronectin and collagen I. In some cases the inductive effect of fibrin on gene expression could be further augmented by the treatment with growth factors such as nerve growth factor. However, the effect of fibrin appeared to be limited, as MSCs did not differentiate into fully mature cells based on immunofluorescence staining after 12 days. This body of work provides a rational approach for studying the interactions of MSC with fibrin, which has important therapeutic implications for the delivery of stem cells.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesenchymal stem cell research · Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Marrow stromal cells as stem cells for nonhematopoietic tissues10.1126/science.276.5309.71 ↗
2. The mesengenic process10.1016/S0094-1298(20)31020-8 ↗
3. Multilineage potential of adult human mesenchymal stem cells10.1126/science.284.5411.143 ↗
4. Mesenchymal stem cells for vascular regeneration10.2217/17460751.3.6.877 ↗
5. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow10.1182/blood.V98.8.2396 ↗
6. Isolation of human mesenchymal stem cells from bone and adipose tissue10.1016/S0091-679X(08)00011-3 ↗
7. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells10.1016/S0301-472X(03)00110-3 ↗
8. (accessed 06.07.10).
9. An extracellular matrix microarray for probing cellular differentiation10.1038/nmeth736 ↗
10. Hydrogels as artificial matrices for human embryonic stem cell self-renewal10.1002/jbm.a.30732 ↗
11. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds10.1073/pnas.1735463100 ↗
12. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure10.1089/ten.2006.12.1587 ↗
13. A PEGylated fibrin patch for mesenchymal stem cell delivery10.1089/ten.2006.12.9 ↗
14. Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix10.1089/ten.tea.2007.0289 ↗
15. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium10.1016/j.jacc.2004.04.040 ↗
16. Controlled compaction with ruthenium-catalyzed photochemical cross-linking of fibrin-based engineered connective tissue10.1016/j.biomaterials.2009.08.039 ↗
17. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction10.1089/107632704323061762 ↗
18. Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium10.2217/rme.09.32 ↗
19. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro10.1089/ten.2006.12.2385 ↗
20. Chondrogenesis of mesenchymal stem cells in gel-like biomaterials in vitro and in vivo10.2741/3020 ↗
21. Human mesenchymal stem cells: Influence of oxygen pressure on proliferation and chondrogenic differentiation in fibrin glue in vitro
22. The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells10.1016/j.biomaterials.2009.09.021 ↗
23. Injectable biopolymers enhance angiogenesis after myocardial infarction10.1089/ten.2005.11.1860 ↗
24. Differential effects of equiaxial and uniaxial strain on mesenchymal stem cells10.1002/bit.20250 ↗
25. NAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis10.1371/journal.pone.0007040 ↗
26. A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction10.1038/nprot.2006.188 ↗
27. A simple microindentation technique for mapping the microscale compliance of soft hydrated materials and tissues10.1002/jbm.a.30812 ↗
28. Cell locomotion and focal adhesions are regulated by substrate flexibility10.1073/pnas.94.25.13661 ↗
29. Myotube assembly on nanofibrous and micropatterned polymers10.1021/nl060060o ↗
30. Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA10.1016/S0736-5748(00)00041-1 ↗
31. Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability10.1016/j.biomaterials.2008.10.047 ↗
32. Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold10.1016/j.biomaterials.2005.01.002 ↗
33. Role of nanofibrous poly(caprolactone) scaffolds in human mesenchymal stem cell attachment and spreading for in vitro bone tissue engineering – response to osteogenic regulators10.1089/ten.tea.2009.0242 ↗
34. Cytokine-induced stable neuronal differentiation of human bone marrow mesenchymal stem cells in a serum/feeder cell-free condition10.1111/j.1440-169X.2005.00810.x ↗
35. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages10.1182/blood-2007-07-103697 ↗
36. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage10.1007/s00441-008-0654-0 ↗